BlackRock Fund Advisors - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 74 filers reported holding ANTHERA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 19.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$820,000
-84.3%
1,263,899
-23.9%
0.00%
-100.0%
Q3 2016$5,229,000
+7.3%
1,659,876
+5.2%
0.00%0.0%
Q2 2016$4,875,000
-12.1%
1,577,721
+3.0%
0.00%0.0%
Q1 2016$5,547,000
-22.5%
1,532,457
-0.6%
0.00%
-50.0%
Q4 2015$7,156,000
+14.4%
1,542,320
+50.2%
0.00%0.0%
Q3 2015$6,255,000
-22.6%
1,027,049
+9.6%
0.00%0.0%
Q2 2015$8,077,000
+2994.6%
936,982
+1505.5%
0.00%
Q1 2015$261,000
+411.8%
58,359
+80.0%
0.00%
Q4 2014$51,000
+112.5%
32,423
+163.5%
0.00%
Q3 2014$24,00012,3030.00%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Sio Capital Management, LLC 2,535,564$7,835,0004.00%
ProQuest Associates IV LLC 1,900,000$5,871,0002.39%
Abingworth LLP 437,994$1,349,0001.41%
Hilltop Park Associates LLC 75,000$232,0000.97%
Broadfin Capital, LLC 1,154,674$3,568,0000.35%
Perceptive Advisors 1,492,156$4,611,0000.32%
Rhenman & Partners Asset Management AB 300,000$927,0000.16%
Rock Springs Capital Management LP 450,000$1,391,0000.10%
WEXFORD CAPITAL LP 145,622$450,0000.08%
BOOTHBAY FUND MANAGEMENT, LLC 15,960$49,0000.02%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders